I

Intra-Cellular Therapies
D

ITCI

128.580
USD
0.05
(0.04%)
مغلق
حجم التداول
53,805
الربح لكل سهم
1
العائد الربحي
-
P/E
-148
حجم السوق
13,671,043,742
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    ALKS
    -0.240
    (-0.68%)
    35.260 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    E
    ESPR
    -0.03500
    (-1.88%)
    1.82500 USD
    GSK
    GSK
    -0.320
    (-0.87%)
    36.650 USD
    LLY
    LLY
    0.67
    (0.08%)
    874.04 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    المزيد
الأخبار
المقالات

العنوان: Intra/Cellular Therapies

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.